About 71 results
Open links in new tab
  1. The New England Journal of Medicine | Research & Review Articles on ...

    The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics of ...

  2. Current Issue | New England Journal of Medicine

    Explore the current issue of The New England Journal of Medicine (Vol. 394 No. 13).

  3. New England Journal of Medicine

    The New England Journal of Medicine publishes high-quality medical research, reviews, and opinions to advance medical science and improve patient care.

  4. Recently Published | The New England Journal of Medicine

    6 days ago · Explore this issue of The New England Journal of Medicine (Vol. 0 No. 0).

  5. Issue Index | New England Journal of Medicine

    Index of all Issues from New England Journal of Medicine

  6. One Pivotal Trial, the New Default Option for FDA Approval — Ending …

    Feb 18, 2026 · This Sounding Board announces a new FDA policy that the default requirement for FDA approvals will be one robust pivotal trial plus confirmatory evidence, rather than two trials.

  7. About NEJM - The New England Journal of Medicine

    The New England Journal of Medicine (NEJM) is recognized as the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed ...

  8. Tirzepatide Once Weekly for the Treatment of Obesity | New England ...

    Jun 4, 2022 · Obesity is a chronic disease that results in substantial global morbidity and mortality. The efficacy and safety of tirzepatide, a novel glucose-dependent insulinotropic polypeptide and glucagon …

  9. NEJM Author Center - The New England Journal of Medicine

    The New England Journal of Medicine (NEJM) continues to lead in the publication of influential, highly cited clinical research.

  10. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

    May 11, 2025 · Tirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without …